La CEO y cofundadora de WIVI VISION, reconocida por Forbes entre las 35 Techwomen de 2024, asume la presidencia de la principal comunidad empresarial del sector de la salud en Cataluña
Read moreUnderstanding the responsibilities involved in Drug Substance and Drug Product manufacturing is essential for making the right strategic decisions. Many biotech companies approaching clinical phases d...
Read moreManufacturing and Controls (CMC) framework ensures that every dose of an investigational product is safe, effective, and consistent in quality. As a candidate moves through the drug development stages...
Read more3PBIOVIAN and the Colombia INC has signed a contract to carry out the development of a biosimilar monoclonal antibody (mAb) for an oncology indication, marking the first biosimilar mAb to be developed...
Read morePharmacelera and Chemspace have announced the launch of a powerful new joint solution that integrates Chemspace Freedom Space 5.0 with Pharmacelera’s flagship virtual screening platform, exaScreen®...
Read moreOryzon Genomics today announced that the United States Patent and Trademark Office has granted U.S. patent US12,564,559 B2, relating to therapeutic combinations of iadademstat, Oryzon’s potent and s...
Read moreThe modern drug development timeline is highly shaped by manufacturing readiness, analytical understanding, and regulatory alignment. While innovation in therapeutic modalities has accelerated target ...
Read moreThe security of a pharmaceutical facility does not end with equipment validation. It begins with the ethical design of its flows and the unwavering protection of the intellectual property that brings ...
Read moreGTX-11, developed by GAT Therapeutics and protected by patent, is a small oral molecule that modulates the TGFβ signalling pathway, a key factor in fibrotic processes, characterised by the excessive ...
Read moreUpdated data from iadademstat’s clinical trials in acute myeloid leukemia to be presented at EHA-2026 in June
Read morePurification is often where development programs stall: inadequate method design, suboptimal column selection, or a poor understanding of critical impurity profiles can consume months of development t...
Read moreIn the pharmaceutical and biotechnology industries, precise terminology is not merely a matter of semantics but a requirement for legal compliance. One of the most recurring questions in our sector is...
Read more